Shalby SHALBY
Orthopaedic-focused hospital chain (joint replacement) based in Ahmedabad, with franchise centres and its own US implant maker, Consensus Orthopedics
Mapped in 1 theme: Hospitals & Healthcare.
Where Shalby sits in the supply chain
Shalby appears in 2 supply-chain layers in one theme, Hospitals & Healthcare.
Hospitals & Healthcare › Medical equipment & implants
Direct supplierOther companies in this layer
Hospitals & Healthcare › Single-specialty chains
OperatorOther companies in this layer
Revenue and profit
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 699 | 805 | 934 | 1,087 | 1,141 |
| Net profit | 54 | 68 | 84 | 2 | 35 |
Latest-year revenue ₹1,141 Cr (FY26, company-wide).
Strengths
- Among India's highest volumes of knee and hip replacement surgery
- Owning an implant maker gives a cost edge and an export business
- Asset-light franchise centres extend reach
Risks
- Knee-implant price caps (NPPA) limit pricing
- Implant business in the US is small and loss-making in some years
- Single-specialty concentration
Common questions
What does Shalby do?
Orthopaedic-focused hospital chain (joint replacement) based in Ahmedabad, with franchise centres and its own US implant maker, Consensus Orthopedics.
Where does Shalby sit in the supply chain?
Shalby (NSE: SHALBY) is mapped in 2 supply-chain layers: Medical equipment & implants (Hospitals & Healthcare) and Single-specialty chains (Hospitals & Healthcare).
Who are Shalby's peers?
In the Single-specialty chains layer of Hospitals & Healthcare: Dr Agarwal's Health Care, Rainbow Children's Medicare, HealthCare Global Enterprises (HCG), Indira IVF (not NSE-listed) and Cloudnine Hospitals (not NSE-listed).
What is Shalby's market cap and valuation?
As of 6 Nov 2026: market cap ₹1,287 Cr, P/E 32.8x, ROCE 6.1%, ROE 2.5%, dividend yield 0%.